These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32032644)

  • 1. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo.
    Pulivendala G; Bale S; Godugu C
    Toxicol Appl Pharmacol; 2020 Mar; 391():114913. PubMed ID: 32032644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways.
    Yin JB; Wang YX; Fan SS; Shang WB; Zhu YS; Peng XR; Zou C; Zhang X
    PLoS One; 2024; 19(9):e0309833. PubMed ID: 39240867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.
    Kataoka S; Umemura A; Okuda K; Taketani H; Seko Y; Nishikawa T; Yamaguchi K; Moriguchi M; Kanbara Y; Arbiser JL; Shima T; Okanoue T; Itoh Y
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways.
    Elfeky MG; Mantawy EM; Gad AM; Fawzy HM; El-Demerdash E
    Life Sci; 2020 Jan; 240():117096. PubMed ID: 31760097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
    Divya T; Velavan B; Sudhandiran G
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
    Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways.
    Zhang Y; Lu W; Zhang X; Lu J; Xu S; Chen S; Zhong Z; Zhou T; Wang Q; Chen J; Liu P
    Pharmacol Res; 2019 Sep; 147():104307. PubMed ID: 31181334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways.
    Liang W; Yang H; Pan L; Wei S; Li Z; Zhang P; Li R; Wu Y; Liu M; Liu X
    Appl Biochem Biotechnol; 2024 Aug; 196(8):4807-4822. PubMed ID: 37971580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
    Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
    Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis.
    Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Kim SH; Kim GY
    Biofactors; 2024; 50(3):477-492. PubMed ID: 38006284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway.
    Sun Q; Hu J; Yu P; Zhu Z; Yu R; Ge C; Li C; Wu G; Lin B; Liu G; Liu M; Bian H; Xu H; Jia S
    Exp Lung Res; 2019; 45(5-6):123-134. PubMed ID: 31210057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro.
    Chiang CK; Sheu ML; Lin YW; Wu CT; Yang CC; Chen MW; Hung KY; Wu KD; Liu SH
    Br J Pharmacol; 2011 Jun; 163(3):586-97. PubMed ID: 21265825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb/p65 phosphorylation and epithelial-mesenchymal transition.
    Cui Y; Jiang L; Yu R; Shao Y; Mei L; Tao Y
    J Ethnopharmacol; 2019 Oct; 243():112096. PubMed ID: 31323300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicyclol attenuates pulmonary fibrosis with silicosis via both canonical and non-canonical TGF-β1 signaling pathways.
    Liu TT; Sun HF; Tang MZ; Shen HR; Shen Z; Han YX; Zhan Y; Jiang JD
    J Transl Med; 2024 Jul; 22(1):682. PubMed ID: 39060930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.